A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the potential effects of rifampin on the
pharmacokinetics (how the drug concentrations change over time) of PCI-32765 in healthy
participants.